Dermapharm Holding SE Logo

Dermapharm Holding SE

ISIN: DE000A2GS5D8 | Ticker: DMP | LEI: 5299009F0KNZINQQQK37
Sector: Health Care – Sub-Industry: Pharmaceuticals
Country: Germany
Website Investor Relations

About Dermapharm Holding SE

Company Description

Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States.

In the "Branded pharmaceuticals and other healthcare products" segment, Dermapharm has approximately 1,300 marketing authorisations with more than 380 active pharmaceutical ingredients. Dermapharm's portfolio of pharmaceuticals, medical devices and food supplements are tailored to selected therapeutic areas in which the Company is a market leader, especially in Germany.

Year founded

1991

Served area

Europe + North America

Headcount

2,373

Headquarters

Lil-Dagover-Ring 7, 82031 Grünwald – Germany

Filings & Publications

2022
2021
2020
2019
2018

2022

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG
ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
GER / ENG
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
ENG / GER
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2019

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG / GER
GER / ENG
ENG / GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2018

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
GER / ENG
ENG / GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
27.06.23 Feldmeier, Dr. Hans-Georg Board Buy EUR 99,902.36
04.04.23 Dreibholz, Benjamin Close relation Buy EUR 449.28
04.04.23 Dreibholz, Katharina Close relation Buy EUR 449.04
03.04.23 Dreibholz, Christof Board Buy EUR 49,024.00
13.01.23 NEON Equity AG Close relation Buy EUR 16,897.00
11.01.23 Dreibholz, Christof Board Buy EUR 49,638.00
17.10.22 Riedel, Oliver Board Buy EUR 11,013.18
17.10.22 Riedel, Oliver Board Buy EUR 8,650.00
17.10.22 Weidenmann, Ralph Supervisory board Buy EUR 2,638.25
14.10.22 Feldmeier, Dr. Hans-Georg Board Buy EUR 98,900.00

Capital markets information

ISIN

DE000A2GS5D8

LEI

5299009F0KNZINQQQK37

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Designated Sponsor

Joh. Berenberg, Gossler & Co. KG

Stifel Europe Bank AG

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

SDAX

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.